Compass Pathways (NASDAQ:CMPS) executives outlined plans for a potential U.S. regulatory filing and commercial launch ...
Discusses Clinical Utility and Evidence Supporting DecisionDx Melanoma Test and DECIDE Study March 23, 2026 4:30 ...
Navigator models, particularly cross-specialty nurse navigation, reduce stress, expedite diagnosis-to-treatment transitions, ...
Clinical decision support (CDS) software plays an increasingly central role in health-care delivery, yet the ambiguous interpretations of regulations result in inconsistent application in clinical ...
11d
Incannex Strengthens Clinical Development Pathway for IHL-42X Following Positive Phase 2 Outcomes
Incannex Healthcare Inc. (Nasdaq: IXHL), a clinical-stage biopharmaceutical company developing innovative combination therapies, today announced an enhanced clinical development strategy for IHL-42X, ...
Test Now Incorporates Enhanced Machine Learning Risk Prediction Algorithm Plans Underway to Commercialise Testing Service Through Trinity ...
Incannex Healthcare Inc. (Nasdaq: IXHL), a clinical-stage biopharmaceutical company developing innovative combination therapies, ...
The developers of sustained acoustic medicine technology and the sam® wearable ultrasound device continue mission of advancing care for arthritis and soft tissue injuries at the Foundation's annual me ...
New CDI-specific education helps align clinical indicators, provider documentation, and compliant coding practices.
Metabolism is more than burning calories. UAB experts explain how metabolism develops from before birth through older ...
April Villarreal Lompoc Valley Medical Center (LVMC) is expanding opportunities for those interested in laboratory medicine ...
Use of numares' metabolite constellation showed a stable urinary metabolic profile in the first 14 days for living donor recipients, enabling accurate early rejection detection -- Deceased donor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results